Assenagon Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $498K | Sell |
|
|||||
|
2025
Q2 | $1.98M | Sell |
|
|||||
|
2025
Q1 | $2.65M | Sell |
|
|||||
|
2024
Q4 | $7.33M | Buy |
|
|||||
|
2024
Q3 | $6.19M | Buy |
|
|||||
|
2024
Q2 | $2.9M | Sell |
|
|||||
|
2024
Q1 | $2.12M | Buy |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | $622K | Buy |
|
|||||
|
2023
Q2 | $700K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $697K | Buy |
|
|||||
|
2022
Q3 | $931K | Sell |
|
|||||
|
2022
Q2 | $4.32M | Buy |
|
|||||
|
2022
Q1 | $2.43M | Sell |
|
|||||
|
2021
Q4 | $6.58M | Buy |
|
|||||
|
2021
Q3 | $1.76M | Buy |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.02M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $827K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.45M | Buy |
|